|
WO2020098517A1
|
|
Use of 4-(benzselenazol-2-yl)arylamine compound in treating stomach cancer or intestinal cancer
|
|
WO2020035058A1
|
|
Pharmaceutical compounds for treating liver diseases and application thereof
|
|
AU2019281613A1
|
|
Compound for treatment or prevention of liver diseases
|
|
CN108484600A
|
|
The URAT1 inhibitor of uricosuric excretion
|
|
CN108727267A
|
|
A kind of URAT1 inhibitor and its application
|
|
WO2018090921A1
|
|
Urat1 inhibitor and use thereof
|
|
WO2017173965A1
|
|
Novel urat1 inhibitor and pharmaceutical application thereof
|
|
EP3348557A1
|
|
Imidazo[1,2a]pyridines for treating or preventing hyperuricemia or gout
|
|
CN106478619A
|
|
One class xanthine oxidase inhibitor and its application
|
|
US2018134673A1
|
|
Compounds for the treatment or prevention of breast cancer
|
